References

Acupuncture Allergies Alzheimer's Disease Androgen Anxiety Disorders Asthma Atherosclerosis Attention Deficit Hyperactivity Disorder Bacterial Vaginosis Biofeedback Bipolar Disorder Birth Control Pills Blood Donation and Transfusion Breast Augmentation and Reduction Breast Cancer Breastfeeding Breast Reconstruction Caregiving Cervical Cancer Chiropractic Chlamydia Cholesterol Chronic Fatigue Syndrome Clinical Trials Colon Cancer Contraception Depression Diabetes Dry Eye Syndrome Eating Disorders Endometriosis Epilepsy Estrogen Fibroids Fibromyalgia Fitness Flu/Colds Gastroesophageal Reflux Disease (GERD) Genetic Testing Genital Herpes Glaucoma Gonorrhea Health Insurance Heart Disease Hepatitis High Blood Pressure HIV/AIDS Homeopathy Human Papillomavirus Hypnosis Hysterectomy Incontinence Infertility Irritable Bowel Syndrome Legal Health Tools Liposuction Lung Cancer Lupus Macular Degeneration Medication Safety Menopause Menstrual Disorders Metabolic Syndrome Migraine Multiple Sclerosis Naturopathy Nonsurgical Aesthetic Procedures Nutrition Obesity Ocular Allergies Oral Health Osteoarthritis Osteopathic Medicine Osteoporosis Ovarian Cancer Overactive Bladder Pain Management Pelvic Organ Prolapse Pelvic Pain Peripheral Arterial Disease Polycystic Ovary Syndrome Pregnancy Premenstrual Syndrome Preparing for Surgery Progesterone Rheumatoid Arthritis Schizophrenia Scleroderma Sexual Dysfunction Sinusitis Sjogren's Syndrome Skin Cancer Skin Health Sleep Disorders Smoking Stress Stroke Substance Abuse Tai Chi Teen Health Thyroid Disorders Trichomoniasis Urinary Tract Conditions Urinary Tract Infection Uterine Cancer Varicose Veins Violence Against Women Vulvodynia Weight Management Yeast Infections Yoga

FDA safety information on Zelnorm. MedWatch. March 30, 2007. http://www.fda.gov. Accessed March 30, 2007.

"Questions and Answers on Zelnorm (tegaserod maleate)." U.S. Food and Drug Administration. Center for Drug Evaluation and Research. http://www.fda.gov. Updated 4/04; Accessed 10/04.

IBS Self Help Group Medication Listing. IBS Self Help and Support Group. Updated April 9, 2004. http://www.ibsgroup.org. Accessed June 7, 2004.

Solvay Pharmaceuticals Research in IBS: Cilansetron. Solvay Pharmaceuticals. Updated April 28, 2003. http://www.solvay-ibs.com. Accessed June 7, 2004.

IBS News. IBS Self Help Group & Support Group and IBSNews.org. Updated June 9, 2004. http://www.ibsnews.org. Accessed June 11, 2004.

"Characteristics of IBS." International Foundation of Functional Gastrointestinal Disorders." Updated May 24, 2004. http://www.aboutibs.org. Accessed June 7, 2004.

Pimentel, M "Eradication of Small Intestinal Bacterial Overgrowth Reduces Symptoms of Irritable Bowel Syndrome" The American Journal of Gastroenterology. Vol. 95, No. 12, Dec., 2000.http://www-east.elsevier.com. Accessed June 7, 2004.

"Irritable Bowel Syndrome" McKinley Health Center. Reviewed April 18, 2001. http://www.mckinley.uiuc.edu. Accessed June 7, 2004.

"Irritable Bowel Syndrome." NIH Publication No. 97-693. National Institutes of Diabetes and Digestive and Kidney Diseases. Posted Feb. 1998 (updated Nov. 2000). http://www.niddk.nih.gov. Accessed June 7, 2004.

"Solvay Pharmaceuticals moves ahead in Irritable Bowel Syndrome with cilansetron" Solvay News. July 18, 2001.http://www.solvay.com. Accessed June 7, 2004.

" What is Glaxo Wellcome telling health care providers today?" FDA/Center for Drug Evaluation and Research (CDER). Updated March 8, 2001. http://www.fda.gov. Accessed June 7, 2004.

Thompson, WG, Longstreth, G, Drossman, D. "Functional bowel disorders and functional abdominal pain." Sept. 1999. Gut. Vol. 45, Suppl. II. 43-7

Drossman, D. "Review article: An integrated approach to the irritable bowel syndrome." Alimentary Pharmacological Therapy. May 1999, Suppl. II. 3-14.

Drossman, D Creed, F, Olden, K. "Psychosocial aspects of the functional gastrointestinal disorders." Gut Sept. 1999, Suppl. II, 25-30.

Camilleri, M. "Economic burden of irritable bowel syndrome: Proposed strategies to control expenditures." Pharmacoeconomics. April 2000. Vol. 17, No. 4, 331-8.

Camilleri, M. "Therapeutic approaches to the treatment of the patient with irritable bowel syndrome." American Journal of Medicine. Nov. 8, 1999. No. 107, Suppl. 5A. 27-32.

"Post infectious Irritable Bowel Syndrome" UNC Center for Functional GI & Motility Disorders. 2001. http://www.med.unc.edu. Accessed June 7, 2004.

"Report on the 4th International Symposium on Functional Gastrointestinal Disorders" March 30th - April 2nd, 2001 Milwaukee, Wisconsin. http://www.iffgd.org. Accessed June 7, 2004.

FDA Approves Restricted Marketing Of Lotronex, June 7, 2002 http://www.fda.gov. Accessed June 7, 2004.

"About irritable bowel syndrome (IBS)" International Foundation for Functional Gastrointestinal Disorders." August 2006. http://www.aboutibs.org/. Accessed August 2006.

"Fast Facts on irritable bowel." Dr.Donnica.com. March 2001 (copyright 2006). http://www.drdonnica.com/. Accessed August 2006.

"Overview of Medications for Irritable Bowel Syndrome." Irritable Bowel Syndrome Self Help and Support Group. March 2006. http://www.ibsgroup.org/. Accessed August 2006.

"Hypnosis Treatment of Irritable Bowel Syndrome." The International Foundation for Functional Gastrointestinal Disorders. November 2004. http://www.aboutibs.org/. Accessed August 2006.